Exploration of Benzenesulfonamide-Bearing Imidazole Derivatives Activity in Triple-Negative Breast Cancer and Melanoma 2D and 3D Cell Cultures

Heterocyclic compounds are one of the main groups of organic compounds possessing wide range of applications in various areas of science and their derivatives are present in many bioactive structures. They display a wide variety of biological activities. Recently, more and more attention has been fo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Benas Balandis, Vytautas Mickevičius, Vilma Petrikaitė
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/c187c460eecc4fa590622c9bb4483d8c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c187c460eecc4fa590622c9bb4483d8c
record_format dspace
spelling oai:doaj.org-article:c187c460eecc4fa590622c9bb4483d8c2021-11-25T18:39:48ZExploration of Benzenesulfonamide-Bearing Imidazole Derivatives Activity in Triple-Negative Breast Cancer and Melanoma 2D and 3D Cell Cultures10.3390/ph141111581424-8247https://doaj.org/article/c187c460eecc4fa590622c9bb4483d8c2021-11-01T00:00:00Zhttps://www.mdpi.com/1424-8247/14/11/1158https://doaj.org/toc/1424-8247Heterocyclic compounds are one of the main groups of organic compounds possessing wide range of applications in various areas of science and their derivatives are present in many bioactive structures. They display a wide variety of biological activities. Recently, more and more attention has been focused to such heterocyclic compounds as azoles. In this work, we have synthesized a series of new imidazole derivatives incorporating a benzenesulfonamide moiety in their structure, which then were evaluated for their cytotoxicity against human triple-negative breast cancer MDA-MB-231 and human malignant melanoma IGR39 cell lines by MTT assay. Benzenesulfonamide-bearing imidazole derivatives containing 4-chloro and 3,4-dichlorosubstituents in benzene ring, and 2-ethylthio and 3-ethyl groups in imidazole ring have been determined as the most active compounds. Half-maximal effective concentration (EC<sub>50</sub>) of the most cytotoxic compound was 27.8 ± 2.8 µM against IGR39 cell line and 20.5 ± 3.6 µM against MDA-MB-231 cell line. Compounds reduced cell colony formation of both cell lines and inhibited the growth and viability of IGR39 cell spheroids more efficiently compared to triple-negative breast cancer spheroids.Benas BalandisVytautas MickevičiusVilma PetrikaitėMDPI AGarticlebenzenesulfonamidesimidazolesalkylatedanticancer activitycolony formationtumor spheroidsMedicineRPharmacy and materia medicaRS1-441ENPharmaceuticals, Vol 14, Iss 1158, p 1158 (2021)
institution DOAJ
collection DOAJ
language EN
topic benzenesulfonamides
imidazoles
alkylated
anticancer activity
colony formation
tumor spheroids
Medicine
R
Pharmacy and materia medica
RS1-441
spellingShingle benzenesulfonamides
imidazoles
alkylated
anticancer activity
colony formation
tumor spheroids
Medicine
R
Pharmacy and materia medica
RS1-441
Benas Balandis
Vytautas Mickevičius
Vilma Petrikaitė
Exploration of Benzenesulfonamide-Bearing Imidazole Derivatives Activity in Triple-Negative Breast Cancer and Melanoma 2D and 3D Cell Cultures
description Heterocyclic compounds are one of the main groups of organic compounds possessing wide range of applications in various areas of science and their derivatives are present in many bioactive structures. They display a wide variety of biological activities. Recently, more and more attention has been focused to such heterocyclic compounds as azoles. In this work, we have synthesized a series of new imidazole derivatives incorporating a benzenesulfonamide moiety in their structure, which then were evaluated for their cytotoxicity against human triple-negative breast cancer MDA-MB-231 and human malignant melanoma IGR39 cell lines by MTT assay. Benzenesulfonamide-bearing imidazole derivatives containing 4-chloro and 3,4-dichlorosubstituents in benzene ring, and 2-ethylthio and 3-ethyl groups in imidazole ring have been determined as the most active compounds. Half-maximal effective concentration (EC<sub>50</sub>) of the most cytotoxic compound was 27.8 ± 2.8 µM against IGR39 cell line and 20.5 ± 3.6 µM against MDA-MB-231 cell line. Compounds reduced cell colony formation of both cell lines and inhibited the growth and viability of IGR39 cell spheroids more efficiently compared to triple-negative breast cancer spheroids.
format article
author Benas Balandis
Vytautas Mickevičius
Vilma Petrikaitė
author_facet Benas Balandis
Vytautas Mickevičius
Vilma Petrikaitė
author_sort Benas Balandis
title Exploration of Benzenesulfonamide-Bearing Imidazole Derivatives Activity in Triple-Negative Breast Cancer and Melanoma 2D and 3D Cell Cultures
title_short Exploration of Benzenesulfonamide-Bearing Imidazole Derivatives Activity in Triple-Negative Breast Cancer and Melanoma 2D and 3D Cell Cultures
title_full Exploration of Benzenesulfonamide-Bearing Imidazole Derivatives Activity in Triple-Negative Breast Cancer and Melanoma 2D and 3D Cell Cultures
title_fullStr Exploration of Benzenesulfonamide-Bearing Imidazole Derivatives Activity in Triple-Negative Breast Cancer and Melanoma 2D and 3D Cell Cultures
title_full_unstemmed Exploration of Benzenesulfonamide-Bearing Imidazole Derivatives Activity in Triple-Negative Breast Cancer and Melanoma 2D and 3D Cell Cultures
title_sort exploration of benzenesulfonamide-bearing imidazole derivatives activity in triple-negative breast cancer and melanoma 2d and 3d cell cultures
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/c187c460eecc4fa590622c9bb4483d8c
work_keys_str_mv AT benasbalandis explorationofbenzenesulfonamidebearingimidazolederivativesactivityintriplenegativebreastcancerandmelanoma2dand3dcellcultures
AT vytautasmickevicius explorationofbenzenesulfonamidebearingimidazolederivativesactivityintriplenegativebreastcancerandmelanoma2dand3dcellcultures
AT vilmapetrikaite explorationofbenzenesulfonamidebearingimidazolederivativesactivityintriplenegativebreastcancerandmelanoma2dand3dcellcultures
_version_ 1718410861627834368